ORCID as entered in ROS

Select Publications
2021, '032 Cognitive deficits are associated with anosmia but not anxio-depressive symptoms in COVID-19', in BMJ Neurology Open, BMJ, pp. a12 - a12, presented at Oral abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.32
,2021, 'O12.4 Diagnosis of Learning Disability is Associated with Approximately 2-Fold Increase in Neurocognitive Impairment in People Living with HIV', in HIV, BMJ Publishing Group Ltd, pp. A43.2 - A44, presented at Abstracts for the STI & HIV World Congress, July 14–17 2021, http://dx.doi.org/10.1136/sextrans-2021-sti.119
,2019, 'Effects of Diffusion MRI Model and Harmonization on the Consistency of Findings in an International Multi-cohort HIV Neuroimaging Study', in Mathematics and Visualization, pp. 203 - 215, http://dx.doi.org/10.1007/978-3-030-05831-9_17
,2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017, http://dx.doi.org/10.26190/unsworks/27403
,2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART study', in Antiviral Therapy, International Medical Press, New York City, USA, presented at The 18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, New York City, USA, 12 September 2016 - 13 September 2016
,2015, 'DECREASED CELLULAR ENERGY IN THE BRAIN FRONTAL WHITE MATTER IS ASSOCIATED WITH PAST IMMUNOSUPPRESION IN CHRONIC HIV INFECTION', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A73 - A74, http://dx.doi.org/10.1136/sextrans-2015-052270.196
,2013, 'COGNITIVE REHABILITATION FOR BREAST CANCER SURVIVORS WITH PERCEIVED COGNITIVE IMPAIRMENT', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 156 - 157, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Moderate neurocognitive decline can be detected over a four-month period using the HIV-dementia scale', in JOURNAL OF NEUROVIROLOGY, SPRINGER, DC, Washington, pp. S51 - S51, presented at 12th International Symposium on NeuroVirology, DC, Washington, 29 October 2013 - 02 November 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325777200107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Glutamate excitotoxicity, cortical and subcortical neuronal damage as potential markers of HIV-associated neurocognitive disorder (HAND): A 1H-MRS and neuropsychological study', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, ITALY, Milan, pp. 22 - 23, presented at 10th International Symposium on NeuroVirology, ITALY, Milan, 12 October 2010 - 16 October 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283409800048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Frontal white matter and Posterior Cingulate abnormalities metabolite abnormalities in older and clinically stable HIV+ individuals', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 67 - 67, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
,2009, 'Cognitive decline over one year among HIV-infected former plasma donors in China', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 19 - 19, presented at 9th International Symposium on NeuroVirology, FL, Miami Beach, 02 June 2009 - 06 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 19 - 19, presented at 9th International Symposium on NeuroVirology, FL, Miami Beach, 02 June 2009 - 06 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in JOURNAL OF NEUROVIROLOGY, TAYLOR & FRANCIS INC, FL, Miami Beach, pp. 19 - 20, presented at 9th International Symposium on NeuroVirology, FL, Miami Beach, 02 June 2009 - 06 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270278700044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Cognitive decline over one year among HIV-infected former plasma donors in China', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P41 - P41
,2009, 'HIV-associated neurocognitive impairment in the context undetectable plasma viral load', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P42 - P42
,2008, 'The effect of age in HIV-associated neurocognitive impairment before and after the era of combination therapy', in Journal of Neurovirology, Taylor & Francis Inc, Philadelphia, PA, USA, pp. P43 - P43, presented at Petrophysics
,2006, 'Variable benefit in neuropsychological function in HIV infected HAART-treated patients', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Diego, pp. A257 - A257, presented at 58th Annual Meeting of the American-Academy-of-Neurology, CA, San Diego, 01 April 2006 - 08 April 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236068103065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Clinically significant cognitive decline is uncommon in virally suppressed HIV. However, there was a signal for abnormal aging and complex impact of psychosocial and socio-economic factors on longitudinal cognitive performance', Virtual, presented at Conference on Retroviruses and Opportunistic Infections, Virtual, 14 February 2022 - 16 February 2022
,2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', Milan, Italy, presented at The 16th European AIDS Conference, Milan, Italy, 25 October 2017 - 27 October 2017
,2015, 'Maraviroc-enhanced CART improves cognition in virally suppressed HAND: a pilot study', Seattle, USA, presented at The 22nd Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, USA, 23 February 2015 - 26 February 2015
,2013, 'Moderate neurocognitive decline can be detected over a four-month period using the HIV-dementia scale (HDS)', Atlanta, USA, presented at The 20th Conference on Retroviruses and Opportunistic Infections (CROI), Atlanta, USA, 03 March 2013 - 06 March 2013
,2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', presented at The Australasian HIV&AIDS Conference, Canberra Australia, 06 November 2017 - 08 November 2017
,2016, 'Concomitant medication use in ART-experienced adults: data from the PAART study', presented at The Australasian HIV&AIDS Conference, Adelaide, Australia, 16 November 2016 - 18 November 2016
,2015, 'Parameters associated with adherence to antiretroviral therapy in HIV-infected Australian adults: the PAART study', presented at The Australasian HIV&AIDS Conference, Brisbane, Australia, 16 September 2015 - 18 September 2015
,2021, 'HIGH LEVELS OF HIV RNA TRANSCRIPTS IN CSF CELLS DESPITE SUPPRESSIVE ART', in SEXUAL HEALTH, CSIRO PUBLISHING, Vol. 18, pp. XVI - XVI, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693686000025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, '030 Brain aging and cardiovascular risk factors in chronic HIV: A longitudinal MRI study', in Oral abstracts, BMJ Publishing Group Ltd, pp. A11.3 - A12, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.30
,2019, 'Cardiovascular Disease Risk Factors and HIV Disease Markers Increase Dementia Risk and Alter White Matter Microstructure in Virally Suppressed HIV Infected Men', in JOURNAL OF NEUROVIROLOGY, SPRINGER, GA, Atlanta, Vol. 25, pp. S6 - S7, presented at 16th International Symposium on NeuroVirology, GA, Atlanta, 12 November 2019 - 16 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000495782800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'HIV Brain Latency May Directly Suppress Brain Cellular Energy', in JOURNAL OF NEUROVIROLOGY, SPRINGER, IL, Chicago, Vol. 24, pp. S19 - S19, presented at Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and the Society-on-NeuroImmune-Pharmacology (SNIP), IL, Chicago, 10 April 2018 - 14 April 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000434755400066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Suggest High Prevalence of Ongoing Disease Activity', in JOURNAL OF NEUROVIROLOGY, SPRINGER, CANADA, Toronto, Vol. 22, pp. S24 - S25, presented at 14th International Symposium on NeuroVirology, CANADA, Toronto, 25 October 2016 - 28 October 2016
,2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389747500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study, http://dx.doi.org/10.1101/2022.06.07.22276020
,2021, Elevation of cell-associated HIV-1 RNA transcripts in CSF CD4+ T cells, despite suppressive antiretroviral therapy, is linked to in vivo brain injury, http://dx.doi.org/10.1101/2021.12.22.21268288
,2019, Smaller limbic structures are associated with greater immunosuppression in over 1000 HIV-infected adults across five continents: Findings from the ENIGMA-HIV Working Group, http://dx.doi.org/10.1101/724583
,Common Brain Volume Signatures Associated with Immunosuppression and Viral Load in Over 1000 Adults Living with HIV Across 5 Continents: Findings from the ENIGMA-HIV Working Group, http://dx.doi.org/10.2139/ssrn.3439553
,Smaller Limbic Structures Are Associated with Immunosuppression and Viral Load in Over 1000 HIV-Infected Adults Across Five Continents: Findings from the ENIGMA-HIV Working Group, http://dx.doi.org/10.2139/ssrn.3444420
,